A Randomized, Double Blind Study To Compare The Effects Of Olmesartan Medoxomil Versus Placebo In Patients With Established Atherosclerosis
Clinical trial NCT00382213 · COMPLETED
Trial details
- NCT number
- NCT00382213
- Sponsor
- Daiichi Sankyo
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-06-01
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.